ADT1692-Varlilumab Biosimilar-Anti-CD27/TNFRSF7 mAb-Research Grade
- +1 609-736-0910
- info@alphalifetech.com
- 90 State Street, STE 700 Office 40, Albany, NY 12207 United States
Product Background
Catalog Number |
ADT1692 |
Product Name |
ADT1692-Varlilumab Biosimilar-Anti-CD27/TNFRSF7 mAb-Research Grade |
Alias |
1F5, CDX-1127 |
Isotype |
IgG1 Kappa |
Clonity |
Monoclonal |
|
Alternate Names CD27 antibody, anti CD27, anti-CD27 antibody, human CD27 antibody, recombinant CD27, CD27 recombinant antibody, CD27 blocking antibody, TNFRSF7 recombinant antibody, TNFRSF7 blocking antibody, anti-TNFRSF7antibody
|
|
Official Symbol |
CD27/TNFRSF7 |
Species |
Human |
Expression Host |
CHO Cells |
Reactivity |
Human |
CAS Number |
1393344-72-3 |
Product Description |
Varlilumab (INN, development code CDX-1127) is a monoclonal antibody designed for immunotherapy for solid tumors and hematologic malignancies. It is an anti-CD27 antibody and helps activate T-cells. |
Mechanism of Action |
Varlilumab is a monoclonal antibody targeting 4-1BB (CD137), a costimulatory receptor on T-cells. |
Metabolism |
Varlilumab has a long half-life and is distributed throughout the bloodstream and tissues. |
Gene ID |
939 |
Size |
100ug,1mg,5mg |
Research Area |
Cancer |
Application |
Elisa, WB |
Purity |
>95% as determined by SDS-PAGE |
Concentration |
Batch dependent |
Buffer |
Supplied in PBS, PH7.5 |
Storage |
Store at -20 °C for 12 months. Store at -80 °C for long term storage. |
Shipping Condition |
Shipped on ice packs. |
Note |
This product is for research use only. |
|
Reference 1. Dong MP, et al. Am J Pathol, 2022 Oct. PMID 35963463
2. Kibler A, et al. Front Immunol, 2022. PMID 35154145,
3. Galliano I, et al. Ital J Dermatol Venerol, 2022 Jun. PMID 34282858
|
FAQ
-
+ -
What is a biosimilar?
A biosimilar is a biological product that is highly similar to an existing approved reference biological product (also known as the originator or reference product), with no clinically meaningful differences in terms of safety, purity, and potency. Biosimilars are developed to be highly similar to the reference product in terms of structure, function, pharmacokinetics, and clinical efficacy. Alpha Lifetech can provide biosimilar antibody products.
-
+ -
How can I obtain Request Quote of the reagent that I received?
Please contact us via email info@alphalifetech.com for detailed information about the product.
-
+ -
Why choose Alpha Lifetech’s product?
Alpha Lifetech's products are chosen for their quality, reliability, and competitive pricing. Our biosimilar antibodies undergo thorough development and testing processes to ensure they meet regulatory requirements and deliver comparable performance to reference products. We prioritize customer satisfaction and strive to provide cost-effective solutions without compromising on quality. -
+ -
How to purify your antibodies?
Protein A/G Chromatography: Protein A and Protein G are affinity chromatography matrices that specifically bind to the Fc region of antibodies, allowing for their purification from complex mixtures.
Ion Exchange Chromatography: Ion exchange chromatography separates proteins based on their net charge at a specific pH.
Size Exclusion Chromatography: Size exclusion chromatography (SEC), also known as gel filtration chromatography, separates proteins based on their size and shape.
Affinity Tag Purification: Some recombinant antibodies are engineered with affinity tags (e.g., His-tag, FLAG-tag) that facilitate purification. Affinity tag purification involves using specific affinity resins or columns that bind to the tag, allowing for purification of the tagged antibodies. Alpha Lifetech has multiple antibody purification strategies. Please contact us via email info@alphalifetech.com for more detailed information.






